메뉴 건너뛰기




Volumn 39, Issue 32, 2018, Pages 2959-2971

Apixaban compared to heparin/Vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: The EMANATE trial

Author keywords

Anticoagulation; Apixaban; Atrial fibrillation; Cardiac imaging; Cardioversion; Heparin Vitamin K antagonist; Stroke

Indexed keywords

ANTIVITAMIN K; APIXABAN; CREATININE; HEPARIN; ANTICOAGULANT AGENT; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE; VITAMIN K GROUP;

EID: 85051425136     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehy148     Document Type: Article
Times cited : (140)

References (21)
  • 3
    • 0026532168 scopus 로고
    • Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter
    • Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 1992;19:851-855.
    • (1992) J Am Coll Cardiol , vol.19 , pp. 851-855
    • Arnold, A.Z.1    Mick, M.J.2    Mazurek, R.P.3    Loop, F.D.4    Trohman, R.G.5
  • 4
    • 0024539309 scopus 로고
    • Anticoagulation for cardioversion of atrial fibrillation
    • Weinberg DM, Mancini J. Anticoagulation for cardioversion of atrial fibrillation. Am J Cardiol 1989;63:745-746.
    • (1989) Am J Cardiol , vol.63 , pp. 745-746
    • Weinberg, D.M.1    Mancini, J.2
  • 6
    • 0014470842 scopus 로고
    • The efficacy of anticoagulant therapy in preventing embolism related to D.C. Electrical conversion of atrial fibrillation
    • Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol 1969;23:208-216.
    • (1969) Am J Cardiol , vol.23 , pp. 208-216
    • Bjerkelund, C.J.1    Orning, O.M.2
  • 15
    • 84978173368 scopus 로고    scopus 로고
    • Apixaban compared with parenteral heparin and/or Vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial
    • Ezekowitz MD, Pollack CV, Sanders P, Halperin JL, Spahr J, Cater N, Petkun W, Breazna A, Kirchhof P, Oldgren J. Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: rationale and design of the EMANATE trial. Am Heart J 2016; 179:59-68.
    • (2016) Am Heart J , vol.179 , pp. 59-68
    • Ezekowitz, M.D.1    Pollack, C.V.2    Sanders, P.3    Halperin, J.L.4    Spahr, J.5    Cater, N.6    Petkun, W.7    Breazna, A.8    Kirchhof, P.9    Oldgren, J.10
  • 16
    • 85055863521 scopus 로고    scopus 로고
    • Princeton, NJ and New York, NY: Bristol-Myers Squibb and Pfizer; February 2018
    • Eliquis (apixaban) [package insert]. Princeton, NJ and New York, NY: Bristol-Myers Squibb and Pfizer; 2018. https://packageinserts.bms.com/pi/pi_eliquis.pdf (February 2018)
    • (2018) Eliquis (Apixaban) [Package Insert]
  • 18
    • 84879894202 scopus 로고    scopus 로고
    • An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American Heart Association/ American Stroke Association
    • American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease
    • Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, Elkind MS, George MG, Hamdan AD, Higashida RT, Hoh BL, Janis LS, Kase CS, Kleindorfer DO, Lee JM, Moseley ME, Peterson ED, Turan TN, Valderrama AL, Vinters HV; American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Council on Nutrition, Physical Activity and Metabolism. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2013;44:2064-2089.
    • (2013) Stroke , vol.44 , pp. 2064-2089
    • Sacco, R.L.1    Kasner, S.E.2    Broderick, J.P.3    Caplan, L.R.4    Connors, J.J.5    Culebras, A.6    Elkind, M.S.7    George, M.G.8    Hamdan, A.D.9    Higashida, R.T.10    Hoh, B.L.11    Janis, L.S.12    Kase, C.S.13    Kleindorfer, D.O.14    Lee, J.M.15    Moseley, M.E.16    Peterson, E.D.17    Turan, T.N.18    Valderrama, A.L.19    Vinters, H.V.20    more..
  • 19
    • 23044505564 scopus 로고    scopus 로고
    • Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
    • Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005;3:692-694.
    • (2005) J Thromb Haemost , vol.3 , pp. 692-694
    • Schulman, S.1    Kearon, C.2
  • 20
    • 84946543850 scopus 로고    scopus 로고
    • Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: Communication from the SSC of the ISTH
    • Kaatz S, Ahmad D, Spyropoulos AC, Schulman S. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 2015;13:2119-2126.
    • (2015) J Thromb Haemost , vol.13 , pp. 2119-2126
    • Kaatz, S.1    Ahmad, D.2    Spyropoulos, A.C.3    Schulman, S.4
  • 21
    • 84973324735 scopus 로고    scopus 로고
    • Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)
    • Lip GYH, Hammerstingl C, Marin F, Cappato R, Ling Meng I, Kirsch B, van Eickels M, Cohen A; On Behalf of the X-TRA study and CLOT-AF registry investigators. Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). Am Heart J 2016;178: 126-134.
    • (2016) Am Heart J , vol.178 , pp. 126-134
    • Lip, G.Y.H.1    Hammerstingl, C.2    Marin, F.3    Cappato, R.4    Ling Meng, I.5    Kirsch, B.6    Van Eickels, M.7    Cohen, A.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.